연구동향 분석

습성 나이관련황반변성에서 항혈관내피성장인자의 유효성과 안전성: 네트워크 메타분석

강민주 신상진 서재경 조송희 최하진 양장미 지동현 2019년

논문상세정보
인용/피인용
' 습성 나이관련황반변성에서 항혈관내피성장인자의 유효성과 안전성: 네트워크 메타분석' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • age-related macular degeneration
  • intravitrealinjection
  • meta analysis
  • ranibizumab
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,312 0

0.0%

' 습성 나이관련황반변성에서 항혈관내피성장인자의 유효성과 안전성: 네트워크 메타분석' 의 참고문헌

  • Risk factors for age-related macular degeneration : an update
    Hyman L [2002]
  • Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
    Mehta H [2018]
  • Prevalence and risk factors for age-related macular degeneration : Korean National Health and Nutrition Examination Survey 2008-2011
    La TY [2014]
  • Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration : outcomes in the Japanese subgroup of the VIEW 2 study
    Ogura Y [2015]
  • Effects of aflibercept for neovascular age-related macular degeneration : a systematic review and meta-analysis of observational comparative studies
    Zhang Y [2017]
  • Current advances in the treatment of neovascular age-related macular degeneration
    Villegas VM [2017]
  • Comparing ranibizumab with bevacizumab
    Biswas P [2011]
  • CADTH Rapid Response Reports. Antivascular endothelial growth factor drugs for the treatment of retinal conditions: a review of the safety [Internet]
  • Anti-vascular endothelial growth factor for neovascular age-related macular degeneration
  • Anti-VEGF therapy for retinal vein occlusions
    Campa C [2016]
  • Anti-VEGF therapy for neovascular AMD and polypoidal choroidal vasculopathy
    Cheung GCM [2017]
  • Anti-VEGF for the management of diabetic macular edema
  • Age-related macular degeneration : economic burden and value-based medicine analysis
    Brown MM [2005]
  • Age-related macular degeneration
    Jager RD [2008]
  • Aflibercept in age-related macular degeneration : evaluating its role as a primary therapeutic option
    Ashraf M [2017]
  • Aflibercept for neovascular age-related macular degeneration
  • A systematic review of the treat and extend treatment regimen with anti-VEGF agents for neovascular age-related macular degeneration
    Gemenetzi M [2017]
  • A randomised doublemasked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration
    Krebs I [2013]